![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 3
Zeitschriftenartikel
Rugo, H. S.; Dieras, V.; Gelmon, K. A.; Finn, R. S.; Slamon, D. J.; Martin, M.; Neven, P.; Shparyk, Y.; Mori, A.; Lu, D. R.; Bhattacharyya, H.; Bartlett, C. Huang; Iyer, S.; Johnston, S.; Ettl, J. und Harbeck, N.
(2018):
Impact of palbociclib plus letrozole on patient-reported health-related quality of life: results from the PALOMA-2 trial.
In: Annals of Oncology, Bd. 29, Nr. 4: S. 888-894
Vanderstichele, A.; Busschaert, P.; Smeets, D.; Nieuwenhuysen, E. van; Leunen, K.; Neven, P.; Amant, F.; Mahner, S.; Braicu, I.; Zeillinger, R.; Coosemans, A.; Timmerman, D.; Lambrechts, D. und Vergote, I.
(2016):
Chromosomal instability in cell-free DNA as a highly specific biomarker for ovarian cancer detection.
In: International Journal of Gynecological Cancer, Bd. 26: S. 4-7
Rugo, H.; Dieras, V.; Gelmon, K. A.; Finn, R.; Slamon, D.; Miguel, M.; Neven, P.; Ettl, J.; Shparyk, Y.; Mori, A.; Lu, D. R.; Bhattacharyya, H.; Bartlett, C. H.; Iyer, S.; Johnston, S. und Harbeck, N.
(2016):
Impact of palbociclib plus letrozole on health related quality of life (HRQOL) compared with letrozole alone in treatment naive postmenopausal patients with ER+HER2-metastatic breast cancer (MBC): results from PALOMA-2.
In: Annals of Oncology, Bd. 27